BiotechTube
QRskin

QRskin

Munich, Germany· Est.
qrskin.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Founded in 2018 and based in Munich, QRskin operates at the intersection of dermatology and digital health. The company is building an integrated platform that leverages artificial intelligence for skin lesion analysis and couples it with telemedicine capabilities to facilitate remote consultations. This approach targets the growing demand for accessible dermatological care and aims to reduce wait times for specialist appointments. As a private, early-stage company, QRskin is likely focused on technology validation, clinical studies, and initial market deployment in Germany and potentially the broader EU.

Dermatology

Technology Platform

Integrated digital health platform combining an AI-powered skin lesion analysis engine for diagnostic support with a telemedicine suite for remote consultations and patient management.

Opportunities

The growing global shortage of dermatologists and long patient wait times create a strong demand for tele-dermatology and AI triage tools.
Supportive digital health policies in Germany and the EU, along with increased patient comfort with remote care post-pandemic, provide a favorable regulatory and market environment.
The core AI technology has potential applications beyond clinical diagnosis, including wellness skincare and pharmaceutical support services.

Risk Factors

The company faces significant regulatory hurdles in obtaining medical device certification (CE Mark) for its AI algorithm.
Clinical validation in real-world settings is required to prove efficacy and gain physician trust.
The market is highly competitive with many well-funded startups and large tech companies developing similar AI dermatology solutions.

Competitive Landscape

QRskin competes in a crowded field of AI dermatology companies such as FotoFinder, Derma.ia, and Skin Analytics, as well as telemedicine platforms offering dermatology services. Large technology firms like Google Health and Apple are also exploring skin analysis AI. Differentiation will depend on regulatory clearance, clinical validation data, integration depth, and success in securing partnerships with healthcare providers.

More companies in Digital Health & Biotech SaaS →More companies in Germany →